Abbott Laboratories (ABT) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 1.31B | 3.31B | 2.79B | 2.05B | 1.42B | 2.87B | 2.71B | 1.96B | 1.02B | 3.04B | 1.88B | 1.2B | 1.14B | 2.33B | 2.78B | 2.41B | 2.06B | 3.07B | 2.7B | 2.13B |
| Operating CF Margin % | 11.78% | 28.93% | 24.51% | 18.37% | 13.68% | 26.13% | 25.43% | 18.89% | 10.29% | 29.67% | 18.51% | 12.06% | 11.73% | 23.05% | 26.71% | 21.41% | 17.36% | 26.74% | 24.72% | 20.82% |
| Operating CF Growth % | -7.2% | 15.59% | 3.03% | 4.44% | 38.24% | -5.6% | 44.11% | 62.93% | -10.32% | 30.61% | -32.48% | -50.08% | -44.65% | -24.16% | 2.92% | 13.25% | -21.69% | -19.25% | 30.74% | 60.97% |
| Net Income | 1.08B | 1.78B | 1.64B | 1.78B | 1.32B | 9.23B | 1.65B | 1.3B | 1.23B | 1.59B | 1.44B | 1.38B | 1.32B | 1.03B | 1.44B | 2.02B | 2.45B | 1.99B | 2.1B | 1.19B |
| Depreciation & Amortization | 730M | 792M | 791M | 777M | 756M | 807M | 801M | 805M | 805M | 813M | 824M | 800M | 806M | 807M | 815M | 822M | 823M | 883M | 847M | 874M |
| Stock-Based Compensation | 317M | 113M | 120M | 142M | 289M | 111M | 117M | 141M | 304M | 114M | 117M | 132M | 281M | 115M | 123M | 142M | 305M | 106M | 114M | 132M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 73M | 65M | 0 | 0 | 0 | 1.11B | -22M | 140M | -748M | 2.04B | -179M | -660M | 0 | 257M | 71M | 0 | 0 | 195M | 0 | 0 |
| Working Capital Changes | -882M | 569M | 232M | -651M | -953M | -8.39B | 163M | -428M | -561M | -1.52B | -321M | -444M | -1.26B | 114M | 336M | -572M | -1.51B | -106M | -360M | -67M |
| Change in Receivables | -42M | 222M | -202M | -410M | -262M | -158M | -57M | -325M | -151M | 68M | -461M | -196M | 233M | 341M | 530M | -188M | -751M | -189M | -394M | 35M |
| Change in Inventory | -420M | 234M | 213M | 3M | -255M | 235M | 220M | -103M | -410M | 295M | 140M | -248M | -419M | -189M | -194M | -476M | -554M | 15M | 71M | -5M |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 179M | 660M | 0 | 0 | -71M | 0 | 0 | 1.29B | 0 | 0 |
| Cash from Investing | -20.32B | -913M | -457M | -582M | -470M | -866M | -594M | -453M | -425M | -824M | -634M | -1.21B | -462M | -632M | -484M | -264M | -360M | -671M | -651M | -264M |
| Capital Expenditures | -399M | -689M | -496M | -502M | -484M | -720M | -556M | -533M | -398M | -755M | -560M | -507M | -380M | -610M | -467M | -379M | -321M | -614M | -461M | -413M |
| CapEx % of Revenue | 3.57% | 6.01% | 4.36% | 4.51% | 4.67% | 6.56% | 5.23% | 5.14% | 3.99% | 7.37% | 5.52% | 5.08% | 3.9% | 6.04% | 4.49% | 3.37% | 2.7% | 5.35% | 4.22% | 4.04% |
| Acquisitions | -19.8B | -50M | -55M | 0 | 0 | 0 | 0 | 1M | 0 | 0 | -51M | -786M | 0 | 0 | 0 | 48M | 0 | -134M | -86M | 48M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 34M | 36M | 4M | -28M | 6M | 4M | 2M | 2M | 1M | 2M | -23M | -706M | 4M | 160M | -14M | 26M | 2M | 173M | 4M | 6M |
| Cash from Financing | 17.31B | -1.4B | -1.76B | -1.1B | -2.06B | -1.86B | -1.58B | -791M | -1.18B | -2.05B | -2.34B | -1.29B | -1.41B | -1.46B | -1.54B | -813M | -3.82B | -1.89B | -1.38B | -1.26B |
| Debt Issued (Net) | 18.48B | -70M | -493M | -15M | -1.04B | -613M | 43M | 160M | -127M | -939M | -1.51B | 12M | -42M | 10M | 24M | 10M | -743M | -196M | -67M | -7M |
| Equity Issued (Net) | -64M | -297M | -236M | 29M | 7M | -315M | -751M | -3M | -226M | -259M | -2M | -426M | -540M | -685M | -798M | -5M | -2.31B | -974M | -579M | -471M |
| Dividends Paid | -1.1B | -1.03B | -1.03B | -1.03B | -1.03B | -958M | -960M | -961M | -957M | -888M | -888M | -890M | -890M | -823M | -826M | -828M | -832M | -798M | -801M | -803M |
| Share Repurchases | -180M | -302M | -305M | -6M | -280M | -315M | -751M | -3M | -226M | -259M | -2M | -426M | -540M | -685M | -798M | -5M | -2.31B | -974M | -579M | -471M |
| Other Financing | 0 | 0 | 0 | -82M | 0 | 25M | 92M | 13M | 134M | 34M | 56M | 15M | 62M | 41M | 57M | 10M | 59M | 82M | 70M | 17M |
| Net Change in Cash | -1.72B | 1.01B | 560M | 419M | -1.08B | 58M | 571M | 703M | -612M | 187M | -1.13B | -1.33B | -721M | 288M | 657M | 1.26B | -2.12B | 497M | 644M | 604M |
| Free Cash Flow | 916M | 2.63B | 2.29B | 1.54B | 933M | 2.15B | 2.15B | 1.43B | 627M | 2.28B | 1.32B | 696M | 763M | 1.72B | 2.31B | 2.03B | 1.74B | 2.45B | 2.24B | 1.72B |
| FCF Margin % | 8.2% | 22.92% | 20.15% | 13.87% | 9.01% | 19.57% | 20.21% | 13.75% | 6.29% | 22.29% | 12.98% | 6.98% | 7.83% | 17.01% | 22.22% | 18.04% | 14.66% | 21.39% | 20.5% | 16.78% |
| FCF Growth % | -1.82% | 22.25% | 6.61% | 8.27% | 48.8% | -5.91% | 63.17% | 105.03% | -17.82% | 33.04% | -43.06% | -65.73% | -56.25% | -30.04% | 3.26% | 18.43% | -22.14% | -21.35% | 42.68% | 152.21% |
| FCF per Share | 0.52 | 1.50 | 1.31 | 0.88 | 0.53 | 1.23 | 1.23 | 0.81 | 0.36 | 1.31 | 0.75 | 0.40 | 0.44 | 0.98 | 1.31 | 1.15 | 0.98 | 1.38 | 1.25 | 0.96 |
| FCF Conversion (FCF/Net Income) | 1.22x | 1.87x | 1.70x | 1.15x | 1.07x | 0.31x | 1.64x | 1.51x | 0.84x | 1.91x | 1.31x | 0.87x | 0.87x | 2.25x | 1.94x | 1.19x | 0.84x | 1.54x | 1.29x | 1.79x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |